Company Filing History:
Years Active: 2012-2016
Title: Conception Nemecek: Innovator in Pharmaceutical Chemistry
Introduction
Conception Nemecek is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of MET inhibitors. With a total of 4 patents to his name, Nemecek's work has the potential to impact medical treatments significantly.
Latest Patents
Among his latest patents, Nemecek has developed compounds known as 6-triazolopyridazine sulfanyl benzothiazole derivatives. These compounds are recognized for their role as MET inhibitors. The disclosures related to these patents detail the compounds' formula and their pharmaceutical compositions, processes for preparation, and their use as medicaments.
Career Highlights
Nemecek has had a distinguished career, working with prominent companies such as Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to collaborate on innovative projects that advance medical science.
Collaborations
Throughout his career, Nemecek has worked alongside talented individuals, including Sylvie Wentzler and Eva Albert. Their collaborative efforts have contributed to the success of various projects in the pharmaceutical sector.
Conclusion
Conception Nemecek's contributions to pharmaceutical chemistry and his innovative patents position him as a key figure in the development of new medical treatments. His work continues to inspire advancements in the field.